The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Lancets-Global Market Insights and Sales Trends 2025
Synopsis
Lancets are a pricking needle used to obtain drops of blood for testing. Lancets are being increasingly used by patients affected by cardiovascular and endocrine-related complications. Lancets are designed to only be used once, and then disposed of in a safe way.
These devices are being used for cholesterol and glucose tests, heelstick screening tests or phenylketonuria (PKU) tests in newborns, as well as for severely burned or scarred emergency patients, extremely obese patients and thrombotic-tendency patients.
The global Lancets market size is expected to reach US$ 2001.4 million by 2029, growing at a CAGR of 4.6% from 2023 to 2029. The market is mainly driven by the significant applications of Lancets in various end use industries. The expanding demands from the Cholesterol Tests, Glucose Tests and Others,, are propelling Lancets market. Safety Lancets, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Ordinary Lancets segment is estimated at % CAGR for the next seven-year period.
The major players in global Lancets market include Roche, Lifescan, BD, etc. The top 3 players occupy about 30% shares of the global market. Europe and North America are main markets, they occupy about 70% of the global market. Ordinary lancets is the main type, with a share about 75%. Glucose tests is the main application, which holds a share about 70%.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Lancets, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Lancets market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Lancets market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Lancets sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Lancets covered in this report include Roche, Lifescan, BD, Ascensia, Abbott, B. Braun, ARKRAY, Terumo and I-SENS, etc.
The global Lancets market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Roche
Lifescan
BD
Ascensia
Abbott
B. Braun
ARKRAY
Terumo
I-SENS
Nipro
Omron
AgaMatrix
Smiths Medical
Sarstedt
Sinocare
Yicheng
Yuwell
Greiner Bio One
Global Lancets market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Lancets market, Segment by Type:
Safety Lancets
Ordinary Lancets
Global Lancets market, by Application
Cholesterol Tests
Glucose Tests
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Lancets manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Lancets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Lancets are a pricking needle used to obtain drops of blood for testing. Lancets are being increasingly used by patients affected by cardiovascular and endocrine-related complications. Lancets are designed to only be used once, and then disposed of in a safe way.
These devices are being used for cholesterol and glucose tests, heelstick screening tests or phenylketonuria (PKU) tests in newborns, as well as for severely burned or scarred emergency patients, extremely obese patients and thrombotic-tendency patients.
The global Lancets market size is expected to reach US$ 2001.4 million by 2029, growing at a CAGR of 4.6% from 2023 to 2029. The market is mainly driven by the significant applications of Lancets in various end use industries. The expanding demands from the Cholesterol Tests, Glucose Tests and Others,, are propelling Lancets market. Safety Lancets, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Ordinary Lancets segment is estimated at % CAGR for the next seven-year period.
The major players in global Lancets market include Roche, Lifescan, BD, etc. The top 3 players occupy about 30% shares of the global market. Europe and North America are main markets, they occupy about 70% of the global market. Ordinary lancets is the main type, with a share about 75%. Glucose tests is the main application, which holds a share about 70%.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Lancets, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Lancets market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Lancets market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Lancets sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Lancets covered in this report include Roche, Lifescan, BD, Ascensia, Abbott, B. Braun, ARKRAY, Terumo and I-SENS, etc.
The global Lancets market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Roche
Lifescan
BD
Ascensia
Abbott
B. Braun
ARKRAY
Terumo
I-SENS
Nipro
Omron
AgaMatrix
Smiths Medical
Sarstedt
Sinocare
Yicheng
Yuwell
Greiner Bio One
Global Lancets market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Lancets market, Segment by Type:
Safety Lancets
Ordinary Lancets
Global Lancets market, by Application
Cholesterol Tests
Glucose Tests
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Lancets manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Lancets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Lancets Market Overview
1.1 Lancets Product Overview
1.2 Lancets Market Segment by Type
1.2.1 Safety Lancets
1.2.2 Ordinary Lancets
1.3 Global Lancets Market Size by Type
1.3.1 Global Lancets Market Size Overview by Type (2018-2029)
1.3.2 Global Lancets Historic Market Size Review by Type (2018-2023)
1.3.3 Global Lancets Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Lancets Sales Breakdown by Type (2018-2023)
1.4.2 Europe Lancets Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Lancets Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Lancets Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Lancets Sales Breakdown by Type (2018-2023)
2 Global Lancets Market Competition by Company
2.1 Global Top Players by Lancets Sales (2018-2023)
2.2 Global Top Players by Lancets Revenue (2018-2023)
2.3 Global Top Players by Lancets Price (2018-2023)
2.4 Global Top Manufacturers Lancets Manufacturing Base Distribution, Sales Area, Product Type
2.5 Lancets Market Competitive Situation and Trends
2.5.1 Lancets Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Lancets Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Lancets as of 2022)
2.7 Date of Key Manufacturers Enter into Lancets Market
2.8 Key Manufacturers Lancets Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Lancets Status and Outlook by Region
3.1 Global Lancets Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Lancets Historic Market Size by Region
3.2.1 Global Lancets Sales in Volume by Region (2018-2023)
3.2.2 Global Lancets Sales in Value by Region (2018-2023)
3.2.3 Global Lancets Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Lancets Forecasted Market Size by Region
3.3.1 Global Lancets Sales in Volume by Region (2024-2029)
3.3.2 Global Lancets Sales in Value by Region (2024-2029)
3.3.3 Global Lancets Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Lancets by Application
4.1 Lancets Market Segment by Application
4.1.1 Cholesterol Tests
4.1.2 Glucose Tests
4.1.3 Others
4.2 Global Lancets Market Size by Application
4.2.1 Global Lancets Market Size Overview by Application (2018-2029)
4.2.2 Global Lancets Historic Market Size Review by Application (2018-2023)
4.2.3 Global Lancets Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Lancets Sales Breakdown by Application (2018-2023)
4.3.2 Europe Lancets Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Lancets Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Lancets Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Lancets Sales Breakdown by Application (2018-2023)
5 North America Lancets by Country
5.1 North America Lancets Historic Market Size by Country
5.1.1 North America Lancets Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Lancets Sales in Volume by Country (2018-2023)
5.1.3 North America Lancets Sales in Value by Country (2018-2023)
5.2 North America Lancets Forecasted Market Size by Country
5.2.1 North America Lancets Sales in Volume by Country (2024-2029)
5.2.2 North America Lancets Sales in Value by Country (2024-2029)
6 Europe Lancets by Country
6.1 Europe Lancets Historic Market Size by Country
6.1.1 Europe Lancets Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Lancets Sales in Volume by Country (2018-2023)
6.1.3 Europe Lancets Sales in Value by Country (2018-2023)
6.2 Europe Lancets Forecasted Market Size by Country
6.2.1 Europe Lancets Sales in Volume by Country (2024-2029)
6.2.2 Europe Lancets Sales in Value by Country (2024-2029)
7 Asia-Pacific Lancets by Region
7.1 Asia-Pacific Lancets Historic Market Size by Region
7.1.1 Asia-Pacific Lancets Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Lancets Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Lancets Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Lancets Forecasted Market Size by Region
7.2.1 Asia-Pacific Lancets Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Lancets Sales in Value by Region (2024-2029)
8 Latin America Lancets by Country
8.1 Latin America Lancets Historic Market Size by Country
8.1.1 Latin America Lancets Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Lancets Sales in Volume by Country (2018-2023)
8.1.3 Latin America Lancets Sales in Value by Country (2018-2023)
8.2 Latin America Lancets Forecasted Market Size by Country
8.2.1 Latin America Lancets Sales in Volume by Country (2024-2029)
8.2.2 Latin America Lancets Sales in Value by Country (2024-2029)
9 Middle East and Africa Lancets by Country
9.1 Middle East and Africa Lancets Historic Market Size by Country
9.1.1 Middle East and Africa Lancets Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Lancets Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Lancets Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Lancets Forecasted Market Size by Country
9.2.1 Middle East and Africa Lancets Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Lancets Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Roche
10.1.1 Roche Company Information
10.1.2 Roche Introduction and Business Overview
10.1.3 Roche Lancets Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Roche Lancets Products Offered
10.1.5 Roche Recent Development
10.2 Lifescan
10.2.1 Lifescan Company Information
10.2.2 Lifescan Introduction and Business Overview
10.2.3 Lifescan Lancets Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Lifescan Lancets Products Offered
10.2.5 Lifescan Recent Development
10.3 BD
10.3.1 BD Company Information
10.3.2 BD Introduction and Business Overview
10.3.3 BD Lancets Sales, Revenue and Gross Margin (2018-2023)
10.3.4 BD Lancets Products Offered
10.3.5 BD Recent Development
10.4 Ascensia
10.4.1 Ascensia Company Information
10.4.2 Ascensia Introduction and Business Overview
10.4.3 Ascensia Lancets Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Ascensia Lancets Products Offered
10.4.5 Ascensia Recent Development
10.5 Abbott
10.5.1 Abbott Company Information
10.5.2 Abbott Introduction and Business Overview
10.5.3 Abbott Lancets Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Abbott Lancets Products Offered
10.5.5 Abbott Recent Development
10.6 B. Braun
10.6.1 B. Braun Company Information
10.6.2 B. Braun Introduction and Business Overview
10.6.3 B. Braun Lancets Sales, Revenue and Gross Margin (2018-2023)
10.6.4 B. Braun Lancets Products Offered
10.6.5 B. Braun Recent Development
10.7 ARKRAY
10.7.1 ARKRAY Company Information
10.7.2 ARKRAY Introduction and Business Overview
10.7.3 ARKRAY Lancets Sales, Revenue and Gross Margin (2018-2023)
10.7.4 ARKRAY Lancets Products Offered
10.7.5 ARKRAY Recent Development
10.8 Terumo
10.8.1 Terumo Company Information
10.8.2 Terumo Introduction and Business Overview
10.8.3 Terumo Lancets Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Terumo Lancets Products Offered
10.8.5 Terumo Recent Development
10.9 I-SENS
10.9.1 I-SENS Company Information
10.9.2 I-SENS Introduction and Business Overview
10.9.3 I-SENS Lancets Sales, Revenue and Gross Margin (2018-2023)
10.9.4 I-SENS Lancets Products Offered
10.9.5 I-SENS Recent Development
10.10 Nipro
10.10.1 Nipro Company Information
10.10.2 Nipro Introduction and Business Overview
10.10.3 Nipro Lancets Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Nipro Lancets Products Offered
10.10.5 Nipro Recent Development
10.11 Omron
10.11.1 Omron Company Information
10.11.2 Omron Introduction and Business Overview
10.11.3 Omron Lancets Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Omron Lancets Products Offered
10.11.5 Omron Recent Development
10.12 AgaMatrix
10.12.1 AgaMatrix Company Information
10.12.2 AgaMatrix Introduction and Business Overview
10.12.3 AgaMatrix Lancets Sales, Revenue and Gross Margin (2018-2023)
10.12.4 AgaMatrix Lancets Products Offered
10.12.5 AgaMatrix Recent Development
10.13 Smiths Medical
10.13.1 Smiths Medical Company Information
10.13.2 Smiths Medical Introduction and Business Overview
10.13.3 Smiths Medical Lancets Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Smiths Medical Lancets Products Offered
10.13.5 Smiths Medical Recent Development
10.14 Sarstedt
10.14.1 Sarstedt Company Information
10.14.2 Sarstedt Introduction and Business Overview
10.14.3 Sarstedt Lancets Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Sarstedt Lancets Products Offered
10.14.5 Sarstedt Recent Development
10.15 Sinocare
10.15.1 Sinocare Company Information
10.15.2 Sinocare Introduction and Business Overview
10.15.3 Sinocare Lancets Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Sinocare Lancets Products Offered
10.15.5 Sinocare Recent Development
10.16 Yicheng
10.16.1 Yicheng Company Information
10.16.2 Yicheng Introduction and Business Overview
10.16.3 Yicheng Lancets Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Yicheng Lancets Products Offered
10.16.5 Yicheng Recent Development
10.17 Yuwell
10.17.1 Yuwell Company Information
10.17.2 Yuwell Introduction and Business Overview
10.17.3 Yuwell Lancets Sales, Revenue and Gross Margin (2018-2023)
10.17.4 Yuwell Lancets Products Offered
10.17.5 Yuwell Recent Development
10.18 Greiner Bio One
10.18.1 Greiner Bio One Company Information
10.18.2 Greiner Bio One Introduction and Business Overview
10.18.3 Greiner Bio One Lancets Sales, Revenue and Gross Margin (2018-2023)
10.18.4 Greiner Bio One Lancets Products Offered
10.18.5 Greiner Bio One Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Lancets Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Lancets Industrial Chain Analysis
11.4 Lancets Market Dynamics
11.4.1 Lancets Industry Trends
11.4.2 Lancets Market Drivers
11.4.3 Lancets Market Challenges
11.4.4 Lancets Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Lancets Distributors
12.3 Lancets Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
